{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:13Z","timestamp":1787772433782,"version":"build-2784847793"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Few reports focused on the sex differences in alopecia areata (AA) treated with steroid pulse therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aimed to investigate the association between the clinical outcomes and distinction of gender in AA patients treated with steroid pulse therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This study retrospectively investigated 32 cases (15 males and 17 females) treated with steroid pulse therapy at the Department of Dermatology at the Shiga University of Medical Science between September 2010 and March 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>The administration of corticosteroid was 500 mg methylprednisolone intravenous infusion for 3 consecutive days. Patients were followed up approximately once a month until March 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      The respective data were analyzed by examining and comparing males and females. Statistical analysis was performed using\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test and \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were no significant differences in periods from the onset of AA to the administration of steroid pulse therapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.2), the degree of severity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.37) and improved rate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0772) between males and females. In contrast, the remission rate was 20% (3 of 15 males) and 71% (12 of 17 females), which was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0042). Previous reports have also shown a significant difference in the remission rate between males and females (males: 32 of 114; females: 51 of 117;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Despite the limitations of a small sample size including the previous reports (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 261), female patients with AA would have better outcomes than male patients after steroid pulse therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_418_21","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:14:59Z","timestamp":1716984899000},"page":"543-546","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Sex Differences in Alopecia Areata Treated with Steroid Pulse Therapy"],"prefix":"10.4103","volume":"67","author":[{"given":"Hiraku","family":"Kokubu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sino","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriki","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240829","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107626","article-title":"Pulse corticosteroid therapy for alopecia areata: Study of 139 patients","volume":"215","author":"Nakajima","year":"2007","journal-title":"Dermatology"},{"key":"R2-11-20240829","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigational assessment guidelines. National alopecia areata foundation","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R3-11-20240829","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/000155555493496","article-title":"Large doses of glucocorticoid in the treatment of alopecia areata","volume":"55","author":"Burton","year":"1975","journal-title":"Acta Derm Venereol"},{"key":"R4-11-20240829","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R5-11-20240829","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000051642","article-title":"High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata","volume":"202","author":"Seiter","year":"2001","journal-title":"Dermatology"},{"key":"R6-11-20240829","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1346-8138.2010.01135.x","article-title":"Prognostic factors in methylprednisolone pulse therapy for alopecia areata","volume":"38","author":"Im","year":"2011","journal-title":"J Dermatol"},{"key":"R7-11-20240829","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000341523","article-title":"Pulse corticosteroid therapy for alopecia areata: Long-term outcome after 10 years","volume":"225","author":"Staumont-Sall\u00e9","year":"2012","journal-title":"Dermatology"},{"key":"R8-11-20240829","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000351559","article-title":"Pulse corticosteroid therapy for alopecia areata in children: A retrospective study","volume":"227","author":"Friedland","year":"2013","journal-title":"Dermatology"},{"key":"R9-11-20240829","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1346-8138.15675","article-title":"Development of a scoring system to predict outcomes of iv corticosteroid pulse therapy in rapidly progressive alopecia areata adopting digital image analysis of hair recovery","volume":"48","author":"Sato","year":"2021","journal-title":"J Dermatol"},{"key":"R10-11-20240829","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/1346-8138.12637","article-title":"Detailed clinicopathological characterization of progressive alopecia areata patients treated with iv corticosteroid pulse therapy toward optimization of inclusion criteria","volume":"41","author":"Sato","year":"2014","journal-title":"J Dermatol"},{"key":"R11-11-20240829","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"R12-11-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0897.2004.00177.x","article-title":"Gender difference in the non-specific and specific immune response in humans","volume":"52","author":"Bouman","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"R13-11-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R14-11-20240829","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.0022-202X.2005.23888.x","article-title":"Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H\/HeJ mice","volume":"125","author":"Freyschmidt-Paul","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R15-11-20240829","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-4362.1996.tb01611.x","article-title":"Alopecia areata: Immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors","volume":"35","author":"Ghersetich","year":"1996","journal-title":"Int J Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_418_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:32Z","timestamp":1787769992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_418_21"}},"subtitle":["A Retrospective Study and Review of Literature"],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_418_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}